Isolation of psychedelic-responsive neurons underlying anxiolytic behavioral states. Published in Science.
Understanding how psychedelics exert therapeutic effects without inducing hallucinogenic side effects is a key challenge in neuropsychiatric drug development. Muir et al. combine multiple cutting-edge neuroscience approaches to dissociate the neural mechanisms underlying the anxiolytic-like and hallucinogenic-like effects of the psychedelic 2,5-dimethoxy-4-iodoamphetamine (DOI). They identify a population of DOI-responsive neurons in the medial prefrontal cortex that mediate anxiolytic-like effects without inducing hallucinogenic-like behaviors, paving the way for the development of more targeted psychedelic therapies.